Roxanne E. Jensen, Ph.D., is a Psychometrician and Program Director in the Outcomes Research Branch, in the Healthcare Delivery Research Program at the National Cancer Institute.
Dr. Jensen’s research interests focus on studying the use of patient-reported outcomes (PROs) in clinical care settings, integration of patient-generated health data into electronic health records, mHealth, and the application of machine learning and other data science methods to evaluate and improve cancer health care delivery.
Dr. Jensen is the scientific lead for the SEER-Medicare Health Outcomes Survey (SEER-MHOS) linked database on patient-reported outcomes. She is also the science officer for two research centers in the Improving Management of SymPtoms Across Cancer Treatments (IMPACT) consortium, a Cancer Moonshot Initiative designed to evaluate the implementation of systematic symptom management in cancer care delivery.
Prior to joining the Outcomes Research Branch, Dr. Jensen was an Assistant Professor in the Department of Oncology and a member of the Cancer Prevention and Control Program at the Lombardi Comprehensive Cancer Center. Dr. Jensen received Ph.D. in Public Health from the Johns Hopkins Bloomberg School of Public Health and her B.A. in Psychology and Classical Studies from the University of Pennsylvania.
She was involved in the development of PatientViewpoint, one of the first web-based patient-reported outcome assessment systems developed for use by clinical oncologists. Since then, she has conducted multiple studies investigating best practices on how to collect, integrate, and report PROs in electronic health records to improve care quality. Dr. Jensen also coordinated the Measuring Your Health (MY-Health) study, a large SEER-linked cancer survivor cohort evaluating the validity and generalizability of using Patient-Reported Outcomes Measurement Information System® (PROMIS) measures within and across cancer populations.